BMI View: Although Denmark's pharmaceutical market is relatively small compared to other Western
European countries, the demand for high quality healthcare will remain elevated by an increasing and
ageing population. This demand could provide opportunities for private ..."
BMI View: Pricing regulations in Denmark reflect the broader trend being felt across the European region.
However, BMI believes Denmark's expanding and ageing population will be a significant factor, ensuring
that demand for healthcare remains high. The government wil ..."
BMI View: Denmark's pharmaceutical market is small compared with those of its Western European neighbours. However, BMI believes the country's high public expenditure on health, stringent regulatory climate (recognised by the US and the EU) and stable, transparent business enviro ..."
OVERVIEW OF THE PHARMACEUTICAL MARKET IN DENMARK
The macroenvironment for the Danish pharmaceutical industry is improving. The centre-left coalition, of the Social Democratic Party, the Socialist People's Party and the Social Liberal Party, took office in October 2011. Denmark ..."